PB PB LEINER
LIVE

Serial Number

79265470

Owner

TESSENDERLO GROUP N.V.

Attorney

Bradley M. Stohry

Filing Date

Jun 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PB PB LEINER Trademark

Serial Number: 79265470 • Registration: 6132463

PB PB LEINER is a trademark filed by TESSENDERLO GROUP N.V. on June 17, 2019. The trademark is classified under Class 1 (Chemicals). The application is currently registered and active.

Owner Contact Info

TESSENDERLO GROUP N.V. (4 trademarks)

Troonstraat 130
Brussel B-1050 , BE

Entity Type: 32

Trademark Details

Filing Date

June 17, 2019

Registration Date

August 25, 2020

Published for Opposition

June 9, 2020

Goods & Services

Protein in raw material form for industrial manufacturing purposes; protein in raw material form for scientific and medical purposes; proteins for industrial purposes; proteins for use in manufacture; proteins for use in the manufacture of food supplements; proteins for the food industry; proteins for use in the manufacture of cosmetics; collagen for industrial purposes; gelatin for industrial purposes; chemical preparations for stimulating cooking for industrial purposes, namely, chemical foaming agents, thickening agents, stabilizing agents, gelling agents, binding agents, emulsifying agents; protein as a raw material for the food industry; protein for use in the manufacture of foodstuffs; proteins for use in the manufacture of food products; protein as a raw material for manufacturing food for human consumption; proteins for use in the manufacture of beverages; proteins for use in the manufacture of food stuffs, namely, proteins which form gels as part of the manufacturing process of human food stuffs; proteins for use in the manufacture of food stuffs, namely, proteins for human foodstuffs which form emulsions as part of the manufacturing process; collagen used as a raw ingredient in the manufacture of cosmetics; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; proteins for use in the manufacture of capsules for pharmaceuticals; proteins for use in the manufacture of pharmaceuticals, namely, proteins for encapsulation and microencapsulation of pharmaceuticals; proteins for use in the manufacture of food for animal consumption; proteins for use in the manufacture of veterinary products; collagen for industrial purposes; collagen for use in the manufacture of pharmaceuticals; collagen for use in the manufacture of foodstuffs; collagen for use in the manufacture of beverages; collagen for use in the manufacture of food supplements; collagen for use in the manufacture of veterinary products; collagen for use in the manufacture of food for animal consumption; collagen for use in the manufacture of capsules for pharmaceuticals; collagen for use in the manufacture of pharmaceuticals, namely, collagen for encapsulation and microencapsulation of pharmaceuticals; non-nutritive mixture of protein in the nature of collagen for use as an ingredient in the manufacture of food, namely, for forming an edible, external layer on food products during the co-extrusion processing of foodstuffs; collagen peptides as a raw material for industrial purposes; collagen peptides for industrial purposes; collagen peptides for use in the manufacture of foodstuffs; collagen peptides for use in the manufacture of beverages; collagen peptides for use in the manufacture of food supplements; collagen peptides used as a raw ingredient in the manufacture of cosmetics; collagen peptides for use in the manufacture of veterinary products; collagen peptides for use in the manufacture of food for animal consumption; collagen peptides for use in the manufacture of capsules for pharmaceuticals; collagen peptides for use in the manufacture of pharmaceuticals, namely, collagen for encapsulation and microencapsulation of pharmaceuticals; collagen peptides for use in the manufacture of coatings for pharmaceutical preparations

Filing History

TEAS SECTION 71 & 15 RECEIVED
Aug 8, 2026 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 25, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 17, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 16, 2020 FIMP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 2, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 2, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 2, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 2, 2020 COAR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 25, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2020 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 13, 2020 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jun 5, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 20, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 20, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2020 NONP
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
May 5, 2020 LOPR
LETTER OF PROTEST EVIDENCE FORWARDED
May 1, 2020 LOPT
ASSIGNED TO LIE
Mar 30, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 20, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 20, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 20, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 20, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2020 TROA
REFUSAL PROCESSED BY IB
Oct 19, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 1, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 1, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 25, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 24, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 7, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 3, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2019 REPR